Pulmonary inflammation causes multiple alterations within the lung , including mucus production , recruitment of inflammatory cells , and airway hyperreactivity (AHR). Measurement of AHR by direct , invasive means (eg , mechanical ventilation)or noninvasive techniques , like whole body plethysmography (WBP) , assesses the severity of pulmonary inflammation in animal models of inflammatory lung disease. Direct measurement of AHR is acknowledged as the most accurate method for assessing airway mechanics , but analysis of all data obtained from WBP may offer insights into which inflammatory aspects of the lung are altered along with AHR. Using WBP , we compared the respiratory parameters of two groups of mice sensitized with cockroach allergen. One group was treated with dexamethasone (Dex) before final challenge (DexAsthma) , while the other group received vehicle treatment (Asthma). Respiratory parameters from plethysmography revealed that Dex-Asthma mice compensated to maintain high minute ventilation , whereas Asthma mice showed significant impairment in minute ventilation despite increased peak expiratory flow (103 ؎ 5 ml/min vs. 69 ؎ 70 ml/ min). The WBP data suggest that enhanced air exchange in the Dex-Asthma mice results from significant decreases in airway mucus production. Additional studies with quantitative morphometry of histological sections confirmed that Dex reduced airway mucus. In conclusion , a detailed examination of WBP parameters can accurately assess the respiratory health of mice and will help direct additional studies. Numerous relevant animal models of disease have advanced the understanding of biology and provided important insights into the pathogenesis of human disease. The vast majority of these studies have been carried out in mice, due to their small size and the extensive characterization of the murine inflammatory system. Several robust murine models of allergic asthma have been developed in recent years, 1 including many experimental systems which induce allergic sensitization to ovalbumin (Ova). Although this system allows close control over the nature of the sensitizing agent, Ova is a relatively poor allergen and requires adjuvant co-administration or relatively high and frequent doses to achieve satisfactory immunization.2-5 Our model, conversely, uses an allergen composed of the defatted, total body extract of German cockroaches (cockroach allergen, CRA) containing appreciable lipopolysaccharide. CRA is a highly potent allergen (robust immunization is achieved with a dose thousands of times less than that required for Ova) and does not require an adjuvant for sensitization.6,7 Campbell et al 7 established the first CRA induced model of asthma in mice and demonstrated robust pulmonary inflammation with many asthma-like features. The complex nature of this allergen and its close correspondence with its urban environmental counterpart makes this model highly applicable to the study of human disease.In most models of allergic airways inflammation, disease severity and or therape...